SGL5213
SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1240305-17-2
- Fòrmula: C37H55N3O8
- Peso molecular:669.85
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-15516
Sotagliflozin -
HY-17638
Mizagliflozin -
HY-14902
Tofogliflozin -
HY-109018
Velagliflozin -
HY-123797
KGA-2727 -
HY-17604
Bexagliflozin -
HY-14894A
Ipragliflozin L-Proline -
HY-15461A
Ertugliflozin L-pyroglutamic acid -
HY-13414
Remogliflozin -
HY-109092
Licogliflozin -
HY-101782
HSK0935 -
HY-15516R
Sotagliflozin (Standard)
Actividad biológica
Descripciòn
IC50 & Target
IC50: 29nM/20 nM (hSGLT1/ hSGLT2)[1].
Chemical Information
-
No. CAS 1240305-17-2
-
Peso molecular 669.85
-
Fòrmula C37H55N3O8
-
SMILES
COC1=C([C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)CO)C=C(CC3=CC=C(/C=C/C(C)(C)C(NC(C)(C)C(NCCN(C)C)=O)=O)C=C3)C(C(C)C)=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
SGL5213 Related Classifications
HY-114308 Related Classifications
Powered by Bioz